Table 3.
Component | Classification | Function | Examples/References |
---|---|---|---|
Therapeutic agents | NSAIDs | Alleviate pain and inflammation, reduce joint swelling, and inhibit osteoarthritis (OA) progression | Ibuprofen [75], Naproxen [76], Celecoxib [77], Methotrexate [78], and Hydroxychloroquine [79] |
Corticosteroids | Alleviate pain and inflammation, reduce joint swelling, and inhibit OA progression | Prednisone [80], Dexamethasone [81], and Triamcinolone [82] | |
Cellular sources and Components | Cells | Promote tissue regeneration, reduce inflammation, and enhance tissue repair | Articular chondrocytes, Nasal chondrocytes, Mesenchymal Stem Cells (MSCs), Adipose-derived Stem Cells (ASCs) [83], and Progenitor cells [84] |
Cytokines | Promote cartilage regeneration | Fibroblast growth factor (FGF), TGF-β [85] | |
Peptides | Promote cartilage regeneration | CK2.1 [86] | |
Platelet-Rich Plasma | Promote cartilage regeneration, reduce inflammation, and enhance tissue repair | Concentrated platelets [87] | |
Gene therapy and Exosome delivery |
Transcription Factors | Enhance chondrocyte differentiation and promote tissue repair | Sox 9 [88] |
Gene Vectors | Enhance chondrocyte differentiation and promote tissue repair | Lentiviral vectors, recombinant adeno-associated virus (rAAV) [89] | |
MSC-Derived Exosomes | Modulate immune response and enhance tissue regeneration | MSC-derived exosomes [90] |